BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34643052)

  • 1. Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer.
    Park IK; Yang SS; Chung E; Cho ES; Lee HS; Shin SJ; Im YC; Park EJ; Baik SH; Lee KY; Kang J
    Cancer Med; 2021 Dec; 10(23):8451-8461. PubMed ID: 34643052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
    Huang CY; Sun FJ; Lee J
    Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer.
    Kim Y; Lee JH; Cho ES; Lee HS; Shin SJ; Park EJ; Baik SH; Lee KY; Kang J
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):860-868. PubMed ID: 36696881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of computed tomography associated body composition measurement changes in metastatic colorectal cancer patients.
    Sevgilioglu ZE; Evrimler S; Iscan G; Kayikcioglu E; Sengul SS; Cetin B
    Acta Radiol; 2023 Nov; 64(11):2849-2857. PubMed ID: 37661639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
    Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
    Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle radiodensity and mortality in patients with colorectal cancer.
    Kroenke CH; Prado CM; Meyerhardt JA; Weltzien EK; Xiao J; Cespedes Feliciano EM; Caan BJ
    Cancer; 2018 Jul; 124(14):3008-3015. PubMed ID: 29797673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
    Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
    Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy.
    Sahin TK; Ozbay Y; Altunbulak AY; Altunbulak HI; Onur MR; Ceylan F; Guven DC; Yalcin S; Dizdar O
    Int J Clin Oncol; 2024 Jun; 29(6):822-831. PubMed ID: 38565751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between low skeletal muscle mass and low skeletal muscle radiodensity with functional impairment, systemic inflammation, and reduced survival in patients with incurable cancer.
    Calixto-Lima L; Wiegert EVM; Oliveira LC; Chaves GV; Bezerra FF; Avesani CM
    JPEN J Parenter Enteral Nutr; 2023 Feb; 47(2):265-275. PubMed ID: 36325962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
    Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
    Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle measurements predict surgical wound complications but not overall survival in patients with soft tissue sarcoma.
    Hirai T; Kobayashi H; Okuma T; Ishibashi Y; Ikegami M; Ohki T; Shinoda Y; Okajima K; Zhang L; Akiyama T; Goto T; Tanaka S
    Jpn J Clin Oncol; 2020 Sep; 50(10):1168-1174. PubMed ID: 32533175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle gauge prediction by a machine learning model in patients with colorectal cancer.
    Lim JY; Kim YM; Lee HS; Kang J
    Nutrition; 2023 Nov; 115():112146. PubMed ID: 37531791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
    Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
    BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia?
    Williams GR; Deal AM; Muss HB; Weinberg MS; Sanoff HK; Nyrop KA; Pergolotti M; Shachar SS
    Oncotarget; 2017 May; 8(20):33658-33665. PubMed ID: 28431396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percentile-based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels.
    Marquardt JP; Roeland EJ; Van Seventer EE; Best TD; Horick NK; Nipp RD; Fintelmann FJ
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):190-202. PubMed ID: 34729952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
    Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase angle as a marker for muscle abnormalities and function in patients with colorectal cancer.
    Souza NC; Avesani CM; Prado CM; Martucci RB; Rodrigues VD; de Pinho NB; Heymsfield SB; Gonzalez MC
    Clin Nutr; 2021 Jul; 40(7):4799-4806. PubMed ID: 34271241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.